BridgeBio Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade BridgeBio Pharma 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BBIO

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. 

CEO
Neil Kumar
CEONeil Kumar
Employees
839
Employees839
Headquarters
Palo Alto, California
HeadquartersPalo Alto, California
Founded
2015
Founded2015
Employees
839
Employees839

BBIO Key Statistics

Market cap
17.66B
Market cap17.66B
Price-Earnings ratio
-24.07
Price-Earnings ratio-24.07
Dividend yield
Dividend yield
Average volume
7.09M
Average volume7.09M
High today
$90.96
High today$90.96
Low today
$90.96
Low today$90.96
Open price
$84.00
Open price$84.00
Volume
1.40K
Volume1.40K
52 Week high
$93.42
52 Week high$93.42
52 Week low
$42.09
52 Week low$42.09

Stock Snapshot

As of today, BridgeBio Pharma(BBIO) shares are valued at $90.96. The company's market cap stands at 17.66B, with a P/E ratio of -24.07.

On 2026-07-10, BridgeBio Pharma(BBIO) stock traded between a low of $90.96 and a high of $90.96. Shares are currently priced at $90.96, which is 0.0% above the low and 0.0% below the high.

BridgeBio Pharma(BBIO) shares are trading with a volume of 1.4K, against a daily average of 7.09M.

In the last year, BridgeBio Pharma(BBIO) shares hit a 52-week high of $93.42 and a 52-week low of $42.09.

In the last year, BridgeBio Pharma(BBIO) shares hit a 52-week high of $93.42 and a 52-week low of $42.09.

BBIO News

Nasdaq 3h
BridgeBio Pharma Moves 15.1% Higher: Will This Strength Last?

BridgeBio Pharma BBIO shares soared 15.1% in the last trading session to close at $90.17. The move was backed by solid volume with far more shares changing hand...

BridgeBio Pharma Moves 15.1% Higher: Will This Strength Last?
Barron's 16h
U.S. Markets Closed Up Thursday; BridgeBio Pharma Led Increases - Barron's

...

U.S. Markets Closed Up Thursday; BridgeBio Pharma Led Increases - Barron's

Analyst ratings

92%

of 24 ratings
Buy
91.7%
Hold
8.3%
Sell
0%

People also own

Based on the portfolios of people who own BBIO. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.